<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>gb-spotlight-20020402-01</ui>
   <ji>GBJ</ji>
   <fm>
      <dochead>Research news</dochead>
      <bibl>
         <title>
            <p>Senescence tale</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Weitzman</snm>
               <mi>B</mi>
               <fnm>Jonathan</fnm>
               <email>jonathanweitzman@hotmail.com</email>
            </au>
         </aug>
         <source>Genome Biology</source>
         <issn>1465-6906</issn>
         <pubdate>2002</pubdate>
         <volume>3</volume>
         <fpage>spotlight-20020402-01</fpage>
         <xrefbib>
            <pubid idtype="doi">10.1186/gb-spotlight-20020402-01</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>2</day>
               <month>4</month>
               <year>2002</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2002</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
      <shortabs>
         <p>Replicative senescence appears to be controlled by changes in the telomeric protein complex rather than telomere loss.</p>
      </shortabs>
   </fm>
   <meta>
      <classifications>
         <classification type="news" subtype="status">Archive</classification>
      </classifications>
   </meta>
   <bdy>
      <sec>
         <st>
            <p/>
         </st>
         <p>Replicative senescence is associated with <abbr bid="B1">telomere shortening</abbr> and the loss from the ends of chromosomes of about 100 bp per population doubling. In the March 19 <abbr bid="B2"><it>Science</it></abbr>, Jan Karlseder and researchers at <abbr bid="B3">Rockefeller University</abbr> claim that the state of the ends, rather than telomere loss, determines the induction of senescence (<it>Science</it> 2002, <b>295</b>:2446-2449). They studied primary human fibroblasts expressing <abbr bid="B4">TRF2</abbr>, a sequence-specific DNA-binding protein that binds to telomeric repeats. TRF2 overexpression caused accelerated telomere shortening, increasing the rate of loss to 165-181 bp per end per population doubling. TRF-dependent telomere shortening required cell division and was independent of the p53 or pRb pathways. TRF2-overexpressing cells did not exhibit premature senescence, but they continued to grow and underwent senescence with telomeres that were considerably shorter than control cultures. The elevated TRF2 levels caused a reduction in chromosomal-end fusions and chromosomal damage. The authors propose that TRF2 protects critically short telomeres. </p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <note>Extension of life-span by introduction of telomerase into normal human cells.</note>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">9454332</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <url>http://www.sciencemag.org</url>
            <note>
               <it>Science</it>
            </note>
         </bibl>
         <bibl id="B3">
            <url>http://www.rockefeller.edu</url>
            <note>Rockefeller University </note>
         </bibl>
         <bibl id="B4">
            <note>Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2.</note>
            <xrefbib>
               <pubid idtype="pmpid">9326950</pubid>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
